Australia s most attractive employers announced; Healthe Care ranked 12th alongside Qantas, Apple and Virgin
The pivotal study for Rivastigamine Multi-Day Transdermal Patch (Rivastigamine MD) has been completed in Germa...
Luye Pharma Group has announced submission of a NDA to the U S FDA for Rykindo®
The company has enacted a multi-faceted development plan for sales, R&D, M&A and external collaborations, not ...
The Sentosa® SQ HIV Genotyping Assay is intended for the detection of HIV-1 Group M genomic drug resistance mu...
Luye Pharma’s new drug LY03010 for the treatment of schizophrenia and schizoaffective disorders has obtained ...
TOP